J&J sells trauma unit to ease Synthes bid
Katy Oglethorpe • Wednesday, 4 April 2012 (over a year ago)
Johnson & Johnson (J&J) has sold its trauma unit to medical device manufacturer Biomet, a concession which it hopes will pave the way for European approval of its US$21 billion takeover of medical device maker Synthes.
Premium Subscription required to view this article
This content can only be accessed by subscribers with premium access.
Please see Subscriptions.
If you are a subscriber, please login: